Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Goodall, Jane

Class:IdPerson:9825805
_displayNameGoodall, Jane
_timestamp2023-01-27 06:21:03
created[InstanceEdit:9825807] Rothfels, Karen, 2023-01-27
firstnameJane
initialJ
surnameGoodall
(author)[LiteratureReference:9825809] Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression
[LiteratureReference:9857178] Mitf regulation of Dia1 controls melanoma proliferation and invasiveness
[LiteratureReference:9858091] Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin
[LiteratureReference:9858093] Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells
[LiteratureReference:9858184] The Brn-2 transcription factor links activated BRAF to melanoma proliferation
[LiteratureReference:9917229] The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression
[Change default viewing format]
No pathways have been reviewed or authored by Goodall, Jane (9825805)